{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:52:22Z","timestamp":1785531142091,"version":"3.56.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000008","name":"David and Lucile Packard Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000008","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.contraception.2025.111360","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T19:45:19Z","timestamp":1767210319000},"page":"111360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Label comprehension study for a proposed over-the-counter progestin-only pill"],"prefix":"10.1016","volume":"158","author":[{"given":"Kate","family":"Grindlay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell D.","family":"Bradford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Pradeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Guillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Laurora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2025.111360_bib1","unstructured":"U.S. Food & Drug Administration. FDA approves first nonprescription daily oral contraceptive. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-nonprescription-daily-oral-contraceptive\u00a0(accessed December 20, 2025)."},{"key":"10.1016\/j.contraception.2025.111360_bib2","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.2105\/AJPH.83.8.1094","article-title":"Should oral contraceptives be available without prescription?","volume":"83","author":"Trussell","year":"1993","journal-title":"Am J Pub Health"},{"key":"10.1016\/j.contraception.2025.111360_bib3","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ogc.2015.07.002","article-title":"Over-the-counter access to oral contraceptives","volume":"42","author":"Grossman","year":"2015","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.contraception.2025.111360_bib4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/jwh.2015.5312","article-title":"Prescription birth control access among U.S. women at risk of unintended pregnancy","volume":"25","author":"Grindlay","year":"2016","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.contraception.2025.111360_bib5","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/01.AOG.0000459866.14114.33","article-title":"Committee opinion no. 615: access to contraception","volume":"125","author":"American College of Obstetricians and Gynecologists","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.111360_bib6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.contraception.2012.01.008","article-title":"Contraindications to progestin-only oral contraceptive pills among reproductive-aged women","volume":"86","author":"White","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111360_bib7","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/AOG.0b013e31818345f0","article-title":"Accuracy of self-screening for contraindications to combined oral contraceptive use","volume":"112","author":"Grossman","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.111360_bib8","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.contraception.2005.12.001","article-title":"Agreement between women's and providers' assessment of hormonal contraceptive risk factors","volume":"73","author":"Shotorbani","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111360_bib9","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/AOG.0b013e31820afc46","article-title":"Continuation of prescribed compared with over-the-counter oral contraceptives","volume":"117","author":"Potter","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.111360_bib10","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.whi.2017.11.006","article-title":"Interest in over-the-counter access to a progestin-only pill among women in the United States","volume":"28","author":"Grindlay","year":"2018","journal-title":"Womens Health Issues"},{"key":"10.1016\/j.contraception.2025.111360_bib11","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.contraception.2013.04.005","article-title":"Interest in over-the-counter access to oral contraceptives among women in the United States","volume":"88","author":"Grossman","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111360_bib12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1363\/46e0714","article-title":"Attitudes toward over-the-counter access to oral contraceptives among a sample of abortion clients in the United States","volume":"46","author":"Grindlay","year":"2014","journal-title":"Perspect Sex Reprod Health"},{"key":"10.1016\/j.contraception.2025.111360_bib13","doi-asserted-by":"crossref","first-page":"657.e1","DOI":"10.1016\/j.ajog.2024.02.006","article-title":"Interest in over-the-counter progestin-only pills among transgender, nonbinary, and gender-expansive individuals in the United States","volume":"230","author":"Grindlay","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.111360_bib14","unstructured":"Long M, Frederiksen B, Ranji U, Diep K, Salganicoff A. Interest in using over-the-counter oral contraceptive pills: findings from the 2022 KFF Women's Health Survey; 2022.\u00a0www.kff.org\/womens-health-policy\/issue-brief\/interest-using-over-the-counter-oral-contraceptive-pills-findings-2022-kff-womens-health-survey\/\u00a0(accessed December 20, 2025)."},{"key":"10.1016\/j.contraception.2025.111360_bib15","unstructured":"U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Guidance for industry label comprehension studies for nonprescription drug products; 2010.\u00a0https:\/\/www.fda.gov\/media\/75626\/download\u00a0(accessed December 20, 2025)."},{"key":"10.1016\/j.contraception.2025.111360_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.contraception.2024.110401","article-title":"Evaluation of consumer self-selection of a proposed over-the-counter, progestin-only daily oral contraceptive","volume":"133","author":"Sober","year":"2024","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111360_bib17","first-page":"124","article-title":"Rapid Estimate of Adult Literacy in Medicine (REALM): a quick reading test for patients","volume":"37","author":"Murphy","year":"1993","journal-title":"J Read"},{"key":"10.1016\/j.contraception.2025.111360_bib18","doi-asserted-by":"crossref","first-page":"e1707","DOI":"10.1542\/peds.2006-1139","article-title":"Development and validation of the Rapid Estimate of Adolescent Literacy in Medicine (REALM-Teen): a tool to screen adolescents for below-grade reading in health care settings","volume":"118","author":"Davis","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.contraception.2025.111360_bib19","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMsa1912403","article-title":"FDA initiative for drug facts label for over-the-counter naloxone","volume":"382","author":"Cohen","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2025.111360_bib20","first-page":"342","article-title":"Comprehension of a prototype over-the-counter label for an emergency contraceptive pill product","volume":"100","author":"Raymond","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.111360_bib21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.contraception.2008.09.004","article-title":"Comprehension of a prototype emergency contraception package label by female adolescents","volume":"79","author":"Raymond","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111360_bib22","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1363\/psrh.12214","article-title":"Pilot label comprehension study for an over-the-counter combined oral contraceptive pill in the United States","volume":"55","author":"Grindlay","year":"2023","journal-title":"Perspect Sex Reprod Health"},{"key":"10.1016\/j.contraception.2025.111360_bib23","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s11096-014-9975-0","article-title":"Design and comprehensibility of over-the-counter product labels and leaflets: a narrative review","volume":"36","author":"Tong","year":"2014","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.contraception.2025.111360_bib24","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/AOG.0000000000004757","article-title":"Comprehension of an over-the-counter drug facts label prototype for a mifepristone and misoprostol medication abortion product","volume":"139","author":"Biggs","year":"2022","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.111360_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7304a1","article-title":"U.S. medical eligibility criteria for contraceptive use, 2024","volume":"73","author":"Nguyen","year":"2024","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.contraception.2025.111360_bib26","unstructured":"American Cancer Society. Breast cancer facts & figures 2024\u20132025. https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/breast-cancer-facts-and-figures\/2024\/breast-cancer-facts-and-figures-2024.pdf (accessed December 20, 2025)."},{"key":"10.1016\/j.contraception.2025.111360_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.conx.2021.100060","article-title":"Use of concurrent multiple methods of contraception in the United States, 2008\u20132015","volume":"3","author":"Kavanaugh","year":"2021","journal-title":"Contracept X"},{"key":"10.1016\/j.contraception.2025.111360_bib28","article-title":"Impacts of the internet on health inequality and healthcare access: a cross-country study","volume":"10","author":"Yu","year":"2022","journal-title":"Front Public Health"},{"key":"10.1016\/j.contraception.2025.111360_bib29","doi-asserted-by":"crossref","DOI":"10.2196\/24947","article-title":"Association of smartphone ownership and internet use with markers of health literacy and access: cross-sectional survey study of perspectives from project PLACE (Population Level Approaches to Cancer Elimination)","volume":"23","author":"Oshima","year":"2021","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.contraception.2025.111360_bib30","unstructured":"US Census Bureau. Census Bureau releases new educational attainment data. https:\/\/www.census.gov\/newsroom\/press-releases\/2023\/educational-attainment-data.html#:\u223c:text=Sex%20*%20In%202022%2C%2030.1%25%20of%20men,as%20their%20highest%20level%20of%20educational%20attainment\u00a0(accessed December 20, 2025)."},{"key":"10.1016\/j.contraception.2025.111360_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.contraception.2024.110388","article-title":"Evaluation of adherence to a daily progestin-only pill in a simulated over-the-counter setting","volume":"133","author":"Laurora","year":"2024","journal-title":"Contraception"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782425005517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782425005517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:06:16Z","timestamp":1778814376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782425005517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":31,"alternative-id":["S0010782425005517"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2025.111360","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Label comprehension study for a proposed over-the-counter progestin-only pill","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2025.111360","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111360"}}